Related Experiment Video

Updated: Jun 1, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Tumor Cell Selective Cytotoxicity and Apoptosis Induction by an Herbal Preparation from Brucea javanica

Hua Gao1, Julie Lamusta, Wei-Fang Zhang

  • 1Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605-2324, USA.

North American Journal of Medicine & Science
|June 10, 2011
PubMed

Insights

Brucea javanica extract selectively kills cancer cells by inducing apoptosis, involving both p53-dependent and independent pathways. Further research may yield new anti-cancer drugs.

Area of Science:

  • Phytochemistry
  • Cancer Biology
  • Molecular Oncology

Background:

  • Brucea javanica exhibits potential anti-cancer properties.
  • The precise mechanisms of action for B. javanica in cancer treatment remain largely unelucidated.
  • Understanding these mechanisms is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the anti-cancer effects of Brucea javanica extracts on various cancer cell lines.
  • To explore the underlying mechanisms of B. javanica-induced cancer cell death.
  • To determine the role of p53 in the anti-cancer activity of B. javanica.

Main Methods:

  • Establishment of tissue culture assays for cancer cell lines.
  • Treatment of cancer cells with aqueous extracts of B. javanica.
  • Analysis of cell viability and induction of apoptosis.
  • Assessment of p53 protein levels in treated cells.

Main Results:

  • The aqueous extract of B. javanica demonstrated selective toxicity towards cancer cells.
  • B. javanica induced apoptosis in cancer cells, suggesting a key mechanism of action.
  • A significant increase in p53 protein levels was observed in apoptotic cancer cells.
  • Both p53-dependent and p53-independent pathways were implicated in B. javanica-mediated cell death.

Conclusions:

  • Brucea javanica possesses selective anti-cancer properties.
  • Apoptosis induction, influenced by p53, is a primary mechanism for B. javanica's anti-cancer effects.
  • These findings support the potential of B. javanica as a source for novel anti-cancer drug development.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.